{
  "ptid_time": "032_S_4386_2016-02-04",
  "img_path": "/data/qiuhui/data/adni/images/032_S_4386/2016-02-04/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 5,816 mm³, 10.5% below the reference mean. With a Z-score of -0.84 (20.1th percentile), this represents normal volume ; whole brain volume measures 939,372 mm³, 1.2% above the reference mean. With a Z-score of 0.14 (55.8th percentile), this represents normal volume ; entorhinal cortex volume measures 4,061 mm³, 17.3% above the reference mean. With a Z-score of 0.93 (82.5th percentile), this represents normal volume ; fusiform gyrus volume measures 17,506 mm³, 8.7% above the reference mean. With a Z-score of 0.65 (74.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,438 mm³, 7.8% above the reference mean. With a Z-score of 0.70 (75.7th percentile), this represents normal volume . ",
  "text_data": "Age is 88.7 years. Gender is Female. Education: 16 years. MMSE: 26.0. MoCA: 23.0. Logical Memory: 9.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.91 SUVR (profound elevated); Amyloid beta: 921.00 pg/mL (normal ); Total tau: 564.60 pg/mL (profound elevated); Phosphorylated tau: 60.04 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume is slightly reduced but still within the normal range (Z-score -0.84), while other brain regions (whole brain, entorhinal cortex, fusiform gyrus, middle temporal gyrus) show normal or above-average volumes. Cognitive scores (MMSE 26, MoCA 23) are borderline but not severely impaired. Biomarkers show **profoundly elevated T-tau, P-tau, and AV45 (amyloid PET)**, suggesting significant Alzheimer's pathology despite normal Aβ levels (possibly due to assay limitations or non-plateaued Aβ accumulation).  \n\n**Diagnosis: Mild Cognitive Impairment (MCI)**  \n**Confidence: Medium** (Biomarkers strongly suggest Alzheimer's pathology, but cognitive scores are near-normal for age, and structural atrophy is not yet pronounced. Progression to dementia is likely but not definitively present at this stage.)  \n\n**Note:** The discrepancy between normal Aβ and elevated AV45 (amyloid PET) warrants clarification—possible lab assay variability or timing of testing. Elevated tau biomarkers support neurodegenerative activity consistent with early AD.",
  "timestamp": "2025-07-26T05:05:06.849928"
}